A review in the December issue of CGH examines the causes of liver disease among the HIV-infected population in the era of antiretroviral therapy (ART). Dr. Kuemmerle speaks to the review's co-author, Dr. Jennifer C. Price of Johns Hopkins School of Medicine, Baltimore, MD; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

A controlled, multicenter, prospective study in the November issue of CGH evaluates the safety and efficacy of Enterra therapy (Medtronic, Inc, Minneapolis, MN) in patients with chronic intractable nausea and vomiting from diabetic gastroparesis. Dr. Kuemmerle speaks to author Dr. Richard McCallum from the University of Kansas Medical Center.  Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

The safety and complications of percutaneous liver biopsy were examined in patients with hepatitis C–related bridging fibrosis or cirrhosis who were enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial. This study appears in the October issue of CGH.  Dr. Kuemmerle speaks to senior author Dr. Leonard Seeff of the Division of Digestive Diseases and Nutrition, National Institute of Health.  Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

A Clinical Practice article in the September issue of CGH looks at a scenario of a 41-Year-Old woman with complaints of intermittent nonbloody diarrhea, abdominal cramping, and bloating.  Dr. Kuemmerle speaks to Dr. Sheila Crowe of the University of Virginia about how to evaluate and treat these symptoms.  Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

A multidisciplinary expert panel has established a set of explicit quality indicators (QIs) for treatment of patients with cirrhosis in the August issue of CGH.  Dr. Kuemmerle speaks with co-author  Dr. Bruce Bacon of St. Louis University School of Medicine.  We also begin a new feature this month highlighting important stories and topics from the August issue of GI and Hepatology News, the AGA's official newspaper.

An editorial in the July issue of CGH summarizes current information and questions about anti–tumor necrosis factor therapy in Crohn's disease.  Dr. Kuemmerle speaks to author Dr. Charles N. Bernstein of the University of Manitoba.  A related article in the same issue examines postsurgical recurrence of Crohn's disease after Low-Dose Maintenance Therapy With Infliximab

Traveler's Diarrhea (TD) is the most common illness among travelers. A paper in the June issue of CGH looks at a typical clinical scenario involving TD, examines current management strategies and evidence, and offers tips for travelers to prevent and treat the disease. Dr. Kuemmerle speaks to the author, Dr. Herbert L. Dupont of Baylor College of Medicine and University of Texas Medical School.

Two clinical scenarios in the “Education Practice” section of May's CGH look at approaches to acute pancreatitis during stages of early management and follow-up, respectively.  Dr. Kuemmerle speaks with author Dr.  Bechien U. Wu of the Brigham and Women's Hospital, Center for Pancreatic Disease, Boston, MA.

A review in the April 2010 issue of CGH summarizes the available evidence regarding colonoscopy and radiographic studies in the management of acute lower intestinal bleeding.  Dr. Kuemmerle speaks to author Dr. Lisa Strate of the University of Washington School of Medicine, Seattle, Washington.

An editorial in the March issue of CGH discusses how physicians can best address the cancer risk of Barrett's Esophagus with patients.  Dr. Kuemmerle speaks with the author, Dr. Nicholas Shaheen of the University of North Carolina at Chapel Hill. See also the related study in the March issue, “Risk of Esophageal Adenocarcinoma and Mortality in Patients with Barrett's Esophagus:  A Systematic Review and Meta-Analysis.”